New ketorolac solution optimized for safety and patient comfort
For ocular uses two of these drugs, ketorolac and diclofenac, proved to be a better fit. In human studies, these drugs proved to be effective and well-tolerated anti-inflammatory and analgesic drugs. The dosing concentration of these topical ophthalmic NSAIDs was determined based upon the ocular tol...
Gespeichert in:
| Veröffentlicht in: | Ophthalmology Times 2004-11, Vol.29 (21), p.16 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 21 |
| container_start_page | 16 |
| container_title | Ophthalmology Times |
| container_volume | 29 |
| creator | Donnenfeld, Eric Waterbury, L David |
| description | For ocular uses two of these drugs, ketorolac and diclofenac, proved to be a better fit. In human studies, these drugs proved to be effective and well-tolerated anti-inflammatory and analgesic drugs. The dosing concentration of these topical ophthalmic NSAIDs was determined based upon the ocular tolerability of the solutions. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_195782745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>776324681</sourcerecordid><originalsourceid>FETCH-proquest_reports_1957827453</originalsourceid><addsrcrecordid>eNqNyjEOgjAUgOHGaCKid3gegKTQEmRyMBonJwc30sAjqQKvto8YPb0MHsDpH_5vJqIszWVSKKXmIpJpqRKpsttSrEK4Sym10joS-wu-4IFMnjpTQ6BuZEsDkGPb2w820JKHYFrkN5ihAWfY4sBQUz8dXotFa7qAm19jsT0dr4dz4jw9RwxceXSTC1Va5sUuK3Su_jFfVjU5iA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195782745</pqid></control><display><type>article</type><title>New ketorolac solution optimized for safety and patient comfort</title><source>Alma/SFX Local Collection</source><creator>Donnenfeld, Eric ; Waterbury, L David</creator><creatorcontrib>Donnenfeld, Eric ; Waterbury, L David</creatorcontrib><description>For ocular uses two of these drugs, ketorolac and diclofenac, proved to be a better fit. In human studies, these drugs proved to be effective and well-tolerated anti-inflammatory and analgesic drugs. The dosing concentration of these topical ophthalmic NSAIDs was determined based upon the ocular tolerability of the solutions.</description><identifier>ISSN: 0193-032X</identifier><identifier>EISSN: 2150-7333</identifier><language>eng</language><publisher>Monmouth Junction: MultiMedia Healthcare Inc</publisher><subject>Acids ; Analgesics ; Anti-inflammatory agents ; Cataracts ; Drug dosages ; Drug therapy ; Edema ; Eye surgery ; Inflammation ; Nonsteroidal anti-inflammatory drugs ; Ophthalmology ; Pain ; Pharmacokinetics ; Pharmacology ; Product reliability ; Proteins ; Rabbits ; Surgical outcomes</subject><ispartof>Ophthalmology Times, 2004-11, Vol.29 (21), p.16</ispartof><rights>Copyright Advanstar Communications, Inc. Nov 1, 2004</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,776,780,787</link.rule.ids></links><search><creatorcontrib>Donnenfeld, Eric</creatorcontrib><creatorcontrib>Waterbury, L David</creatorcontrib><title>New ketorolac solution optimized for safety and patient comfort</title><title>Ophthalmology Times</title><description>For ocular uses two of these drugs, ketorolac and diclofenac, proved to be a better fit. In human studies, these drugs proved to be effective and well-tolerated anti-inflammatory and analgesic drugs. The dosing concentration of these topical ophthalmic NSAIDs was determined based upon the ocular tolerability of the solutions.</description><subject>Acids</subject><subject>Analgesics</subject><subject>Anti-inflammatory agents</subject><subject>Cataracts</subject><subject>Drug dosages</subject><subject>Drug therapy</subject><subject>Edema</subject><subject>Eye surgery</subject><subject>Inflammation</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Ophthalmology</subject><subject>Pain</subject><subject>Pharmacokinetics</subject><subject>Pharmacology</subject><subject>Product reliability</subject><subject>Proteins</subject><subject>Rabbits</subject><subject>Surgical outcomes</subject><issn>0193-032X</issn><issn>2150-7333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqNyjEOgjAUgOHGaCKid3gegKTQEmRyMBonJwc30sAjqQKvto8YPb0MHsDpH_5vJqIszWVSKKXmIpJpqRKpsttSrEK4Sym10joS-wu-4IFMnjpTQ6BuZEsDkGPb2w820JKHYFrkN5ihAWfY4sBQUz8dXotFa7qAm19jsT0dr4dz4jw9RwxceXSTC1Va5sUuK3Su_jFfVjU5iA</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>Donnenfeld, Eric</creator><creator>Waterbury, L David</creator><general>MultiMedia Healthcare Inc</general><scope>3V.</scope><scope>7RQ</scope><scope>7WY</scope><scope>7X7</scope><scope>7XB</scope><scope>883</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>L.-</scope><scope>M0F</scope><scope>M0R</scope><scope>M0S</scope><scope>M2P</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>S0X</scope><scope>U9A</scope></search><sort><creationdate>20041101</creationdate><title>New ketorolac solution optimized for safety and patient comfort</title><author>Donnenfeld, Eric ; Waterbury, L David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_1957827453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acids</topic><topic>Analgesics</topic><topic>Anti-inflammatory agents</topic><topic>Cataracts</topic><topic>Drug dosages</topic><topic>Drug therapy</topic><topic>Edema</topic><topic>Eye surgery</topic><topic>Inflammation</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Ophthalmology</topic><topic>Pain</topic><topic>Pharmacokinetics</topic><topic>Pharmacology</topic><topic>Product reliability</topic><topic>Proteins</topic><topic>Rabbits</topic><topic>Surgical outcomes</topic><toplevel>online_resources</toplevel><creatorcontrib>Donnenfeld, Eric</creatorcontrib><creatorcontrib>Waterbury, L David</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Career & Technical Education Database</collection><collection>ABI/INFORM Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Trade & Industry (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Trade & Industry</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Ophthalmology Times</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donnenfeld, Eric</au><au>Waterbury, L David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New ketorolac solution optimized for safety and patient comfort</atitle><jtitle>Ophthalmology Times</jtitle><date>2004-11-01</date><risdate>2004</risdate><volume>29</volume><issue>21</issue><spage>16</spage><pages>16-</pages><issn>0193-032X</issn><eissn>2150-7333</eissn><abstract>For ocular uses two of these drugs, ketorolac and diclofenac, proved to be a better fit. In human studies, these drugs proved to be effective and well-tolerated anti-inflammatory and analgesic drugs. The dosing concentration of these topical ophthalmic NSAIDs was determined based upon the ocular tolerability of the solutions.</abstract><cop>Monmouth Junction</cop><pub>MultiMedia Healthcare Inc</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0193-032X |
| ispartof | Ophthalmology Times, 2004-11, Vol.29 (21), p.16 |
| issn | 0193-032X 2150-7333 |
| language | eng |
| recordid | cdi_proquest_reports_195782745 |
| source | Alma/SFX Local Collection |
| subjects | Acids Analgesics Anti-inflammatory agents Cataracts Drug dosages Drug therapy Edema Eye surgery Inflammation Nonsteroidal anti-inflammatory drugs Ophthalmology Pain Pharmacokinetics Pharmacology Product reliability Proteins Rabbits Surgical outcomes |
| title | New ketorolac solution optimized for safety and patient comfort |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A31%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20ketorolac%20solution%20optimized%20for%20safety%20and%20patient%20comfort&rft.jtitle=Ophthalmology%20Times&rft.au=Donnenfeld,%20Eric&rft.date=2004-11-01&rft.volume=29&rft.issue=21&rft.spage=16&rft.pages=16-&rft.issn=0193-032X&rft.eissn=2150-7333&rft_id=info:doi/&rft_dat=%3Cproquest%3E776324681%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195782745&rft_id=info:pmid/&rfr_iscdi=true |